Global Metastatic Malignant Melanoma Therapy Market Insights, Forecast to 2028

Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, in order to reduce the cardiopulmonary compression.Chemotherapy and immunotherapy can be used in patients with better systemic status, but malignant melanoma is not sensitive to the former, while the latter has a certain effect on enhancing the patient's immunity.Radiotherapy can be used as an experimental therapy and can also confirm the presence or absence of cardiac metastasis.Arrhythmias are sometimes controlled by digitalis therapy.

Market Analysis and Insights: Global Metastatic Malignant Melanoma Therapy Market

The global Metastatic Malignant Melanoma Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Immunotherapy accounting for % of the Metastatic Malignant Melanoma Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.

China Metastatic Malignant Melanoma Therapy market size is valued at US$ million in 2021, while the North America and Europe Metastatic Malignant Melanoma Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Metastatic Malignant Melanoma Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Malignant Melanoma Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Malignant Melanoma Therapy market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Malignant Melanoma Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Malignant Melanoma Therapy market.

Global Metastatic Malignant Melanoma Therapy Scope and Market Size

Metastatic Malignant Melanoma Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Metastatic Malignant Melanoma Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Immunotherapy

Targeted Therapy

Other

Hospital

Medical Research Organization

Other

Merck

Pfizer

Janssen Biotech

Roche

Navidea

Novartis

Bristol-Myers Squibb

Enzon Pharmaceuticals

Exelixis

GlaxoSmithKline

Ono Pharmaceutical

Amgen

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Metastatic Malignant Melanoma Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Immunotherapy

1.2.3 Targeted Therapy

1.2.4 Other

1.3 Market by Application

1.3.1 Global Metastatic Malignant Melanoma Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Medical Research Organization

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

2.1 Global Metastatic Malignant Melanoma Therapy Market Perspective (2017-2028)

2.2 Metastatic Malignant Melanoma Therapy Growth Trends by Region

2.2.1 Metastatic Malignant Melanoma Therapy Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Metastatic Malignant Melanoma Therapy Historic Market Size by Region (2017-2022)

2.2.3 Metastatic Malignant Melanoma Therapy Forecasted Market Size by Region (2023-2028)

2.3 Metastatic Malignant Melanoma Therapy Market Dynamics

2.3.1 Metastatic Malignant Melanoma Therapy Industry Trends

2.3.2 Metastatic Malignant Melanoma Therapy Market Drivers

2.3.3 Metastatic Malignant Melanoma Therapy Market Challenges

2.3.4 Metastatic Malignant Melanoma Therapy Market Restraints

3.1 Global Top Metastatic Malignant Melanoma Therapy Players by Revenue

3.1.1 Global Top Metastatic Malignant Melanoma Therapy Players by Revenue (2017-2022)

3.1.2 Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Players (2017-2022)

3.2 Global Metastatic Malignant Melanoma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Metastatic Malignant Melanoma Therapy Revenue

3.4 Global Metastatic Malignant Melanoma Therapy Market Concentration Ratio

3.4.1 Global Metastatic Malignant Melanoma Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Metastatic Malignant Melanoma Therapy Revenue in 2021

3.5 Metastatic Malignant Melanoma Therapy Key Players Head office and Area Served

3.6 Key Players Metastatic Malignant Melanoma Therapy Product Solution and Service

3.7 Date of Enter into Metastatic Malignant Melanoma Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Metastatic Malignant Melanoma Therapy Historic Market Size by Type (2017-2022)

4.2 Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Type (2023-2028)

5.1 Global Metastatic Malignant Melanoma Therapy Historic Market Size by Application (2017-2022)

5.2 Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Application (2023-2028)

6.1 North America Metastatic Malignant Melanoma Therapy Market Size (2017-2028)

6.2 North America Metastatic Malignant Melanoma Therapy Market Size by Type

6.2.1 North America Metastatic Malignant Melanoma Therapy Market Size by Type (2017-2022)

6.2.2 North America Metastatic Malignant Melanoma Therapy Market Size by Type (2023-2028)

6.2.3 North America Metastatic Malignant Melanoma Therapy Market Share by Type (2017-2028)

6.3 North America Metastatic Malignant Melanoma Therapy Market Size by Application

6.3.1 North America Metastatic Malignant Melanoma Therapy Market Size by Application (2017-2022)

6.3.2 North America Metastatic Malignant Melanoma Therapy Market Size by Application (2023-2028)

6.3.3 North America Metastatic Malignant Melanoma Therapy Market Share by Application (2017-2028)

6.4 North America Metastatic Malignant Melanoma Therapy Market Size by Country

6.4.1 North America Metastatic Malignant Melanoma Therapy Market Size by Country (2017-2022)

6.4.2 North America Metastatic Malignant Melanoma Therapy Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7.1 Europe Metastatic Malignant Melanoma Therapy Market Size (2017-2028)

7.2 Europe Metastatic Malignant Melanoma Therapy Market Size by Type

7.2.1 Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2017-2022)

7.2.2 Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2023-2028)

7.2.3 Europe Metastatic Malignant Melanoma Therapy Market Share by Type (2017-2028)

7.3 Europe Metastatic Malignant Melanoma Therapy Market Size by Application

7.3.1 Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2017-2022)

7.3.2 Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2023-2028)

7.3.3 Europe Metastatic Malignant Melanoma Therapy Market Share by Application (2017-2028)

7.4 Europe Metastatic Malignant Melanoma Therapy Market Size by Country

7.4.1 Europe Metastatic Malignant Melanoma Therapy Market Size by Country (2017-2022)

7.4.2 Europe Metastatic Malignant Melanoma Therapy Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8.1 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size (2017-2028)

8.2 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Type

8.2.1 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Share by Type (2017-2028)

8.3 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Application

8.3.1 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Share by Application (2017-2028)

8.4 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Region

8.4.1 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Metastatic Malignant Melanoma Therapy Market Size (2017-2028)

9.2 Latin America Metastatic Malignant Melanoma Therapy Market Size by Type

9.2.1 Latin America Metastatic Malignant Melanoma Therapy Market Size by Type (2017-2022)

9.2.2 Latin America Metastatic Malignant Melanoma Therapy Market Size by Type (2023-2028)

9.2.3 Latin America Metastatic Malignant Melanoma Therapy Market Share by Type (2017-2028)

9.3 Latin America Metastatic Malignant Melanoma Therapy Market Size by Application

9.3.1 Latin America Metastatic Malignant Melanoma Therapy Market Size by Application (2017-2022)

9.3.2 Latin America Metastatic Malignant Melanoma Therapy Market Size by Application (2023-2028)

9.3.3 Latin America Metastatic Malignant Melanoma Therapy Market Share by Application (2017-2028)

9.4 Latin America Metastatic Malignant Melanoma Therapy Market Size by Country

9.4.1 Latin America Metastatic Malignant Melanoma Therapy Market Size by Country (2017-2022)

9.4.2 Latin America Metastatic Malignant Melanoma Therapy Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size (2017-2028)

10.2 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Type

10.2.1 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Share by Type (2017-2028)

10.3 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Application

10.3.1 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Share by Application (2017-2028)

10.4 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Country

10.4.1 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Metastatic Malignant Melanoma Therapy Introduction

11.1.4 Merck Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022)

11.1.5 Merck Recent Developments

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Metastatic Malignant Melanoma Therapy Introduction

11.2.4 Pfizer Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022)

11.2.5 Pfizer Recent Developments

11.3 Janssen Biotech

11.3.1 Janssen Biotech Company Details

11.3.2 Janssen Biotech Business Overview

11.3.3 Janssen Biotech Metastatic Malignant Melanoma Therapy Introduction

11.3.4 Janssen Biotech Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022)

11.3.5 Janssen Biotech Recent Developments

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche Metastatic Malignant Melanoma Therapy Introduction

11.4.4 Roche Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022)

11.4.5 Roche Recent Developments

11.5 Navidea

11.5.1 Navidea Company Details

11.5.2 Navidea Business Overview

11.5.3 Navidea Metastatic Malignant Melanoma Therapy Introduction

11.5.4 Navidea Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022)

11.5.5 Navidea Recent Developments

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Metastatic Malignant Melanoma Therapy Introduction

11.6.4 Novartis Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022)

11.6.5 Novartis Recent Developments

11.7 Bristol-Myers Squibb

11.7.1 Bristol-Myers Squibb Company Details

11.7.2 Bristol-Myers Squibb Business Overview

11.7.3 Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Introduction

11.7.4 Bristol-Myers Squibb Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022)

11.7.5 Bristol-Myers Squibb Recent Developments

11.8 Enzon Pharmaceuticals

11.8.1 Enzon Pharmaceuticals Company Details

11.8.2 Enzon Pharmaceuticals Business Overview

11.8.3 Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Introduction

11.8.4 Enzon Pharmaceuticals Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022)

11.8.5 Enzon Pharmaceuticals Recent Developments

11.9 Exelixis

11.9.1 Exelixis Company Details

11.9.2 Exelixis Business Overview

11.9.3 Exelixis Metastatic Malignant Melanoma Therapy Introduction

11.9.4 Exelixis Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022)

11.9.5 Exelixis Recent Developments

11.10 GlaxoSmithKline

11.10.1 GlaxoSmithKline Company Details

11.10.2 GlaxoSmithKline Business Overview

11.10.3 GlaxoSmithKline Metastatic Malignant Melanoma Therapy Introduction

11.10.4 GlaxoSmithKline Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022)

11.10.5 GlaxoSmithKline Recent Developments

11.11 Ono Pharmaceutical

11.11.1 Ono Pharmaceutical Company Details

11.11.2 Ono Pharmaceutical Business Overview

11.11.3 Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Introduction

11.11.4 Ono Pharmaceutical Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022)

11.11.5 Ono Pharmaceutical Recent Developments

11.12 Amgen

11.12.1 Amgen Company Details

11.12.2 Amgen Business Overview

11.12.3 Amgen Metastatic Malignant Melanoma Therapy Introduction

11.12.4 Amgen Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022)

11.12.5 Amgen Recent Developments

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

List of Tables

    Table 1. Global Metastatic Malignant Melanoma Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Immunotherapy

    Table 3. Key Players of Targeted Therapy

    Table 4. Key Players of Other

    Table 5. Global Metastatic Malignant Melanoma Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 6. Global Metastatic Malignant Melanoma Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 7. Global Metastatic Malignant Melanoma Therapy Market Size by Region (2017-2022) & (US$ Million)

    Table 8. Global Metastatic Malignant Melanoma Therapy Market Share by Region (2017-2022)

    Table 9. Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 10. Global Metastatic Malignant Melanoma Therapy Market Share by Region (2023-2028)

    Table 11. Metastatic Malignant Melanoma Therapy Market Trends

    Table 12. Metastatic Malignant Melanoma Therapy Market Drivers

    Table 13. Metastatic Malignant Melanoma Therapy Market Challenges

    Table 14. Metastatic Malignant Melanoma Therapy Market Restraints

    Table 15. Global Metastatic Malignant Melanoma Therapy Revenue by Players (2017-2022) & (US$ Million)

    Table 16. Global Metastatic Malignant Melanoma Therapy Revenue Share by Players (2017-2022)

    Table 17. Global Top Metastatic Malignant Melanoma Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Malignant Melanoma Therapy as of 2021)

    Table 18. Ranking of Global Top Metastatic Malignant Melanoma Therapy Companies by Revenue (US$ Million) in 2021

    Table 19. Global 5 Largest Players Market Share by Metastatic Malignant Melanoma Therapy Revenue (CR5 and HHI) & (2017-2022)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Metastatic Malignant Melanoma Therapy Product Solution and Service

    Table 22. Date of Enter into Metastatic Malignant Melanoma Therapy Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Metastatic Malignant Melanoma Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 25. Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Type (2017-2022)

    Table 26. Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 27. Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Type (2023-2028)

    Table 28. Global Metastatic Malignant Melanoma Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 29. Global Metastatic Malignant Melanoma Therapy Revenue Share by Application (2017-2022)

    Table 30. Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 31. Global Metastatic Malignant Melanoma Therapy Revenue Share by Application (2023-2028)

    Table 32. North America Metastatic Malignant Melanoma Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 33. North America Metastatic Malignant Melanoma Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 34. North America Metastatic Malignant Melanoma Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 35. North America Metastatic Malignant Melanoma Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 36. North America Metastatic Malignant Melanoma Therapy Market Size by Country (2017-2022) & (US$ Million)

    Table 37. North America Metastatic Malignant Melanoma Therapy Market Size by Country (2023-2028) & (US$ Million)

    Table 38. Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 39. Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 40. Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 41. Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 42. Europe Metastatic Malignant Melanoma Therapy Market Size by Country (2017-2022) & (US$ Million)

    Table 43. Europe Metastatic Malignant Melanoma Therapy Market Size by Country (2023-2028) & (US$ Million)

    Table 44. Asia Pacific Metastatic Malignant Melanoma Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 45. Asia Pacific Metastatic Malignant Melanoma Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 46. Asia Pacific Metastatic Malignant Melanoma Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 47. Asia Pacific Metastatic Malignant Melanoma Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 48. Asia Pacific Metastatic Malignant Melanoma Therapy Market Size by Region (2017-2022) & (US$ Million)

    Table 49. Asia Pacific Metastatic Malignant Melanoma Therapy Market Size by Region (2023-2028) & (US$ Million)

    Table 50. Latin America Metastatic Malignant Melanoma Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 51. Latin America Metastatic Malignant Melanoma Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 52. Latin America Metastatic Malignant Melanoma Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 53. Latin America Metastatic Malignant Melanoma Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 54. Latin America Metastatic Malignant Melanoma Therapy Market Size by Country (2017-2022) & (US$ Million)

    Table 55. Latin America Metastatic Malignant Melanoma Therapy Market Size by Country (2023-2028) & (US$ Million)

    Table 56. Middle East and Africa Metastatic Malignant Melanoma Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 57. Middle East and Africa Metastatic Malignant Melanoma Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 58. Middle East and Africa Metastatic Malignant Melanoma Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 59. Middle East and Africa Metastatic Malignant Melanoma Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 60. Middle East and Africa Metastatic Malignant Melanoma Therapy Market Size by Country (2017-2022) & (US$ Million)

    Table 61. Middle East and Africa Metastatic Malignant Melanoma Therapy Market Size by Country (2023-2028) & (US$ Million)

    Table 62. Merck Company Details

    Table 63. Merck Business Overview

    Table 64. Merck Metastatic Malignant Melanoma Therapy Product

    Table 65. Merck Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022) & (US$ Million)

    Table 66. Merck Recent Developments

    Table 67. Pfizer Company Details

    Table 68. Pfizer Business Overview

    Table 69. Pfizer Metastatic Malignant Melanoma Therapy Product

    Table 70. Pfizer Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022) & (US$ Million)

    Table 71. Pfizer Recent Developments

    Table 72. Janssen Biotech Company Details

    Table 73. Janssen Biotech Business Overview

    Table 74. Janssen Biotech Metastatic Malignant Melanoma Therapy Product

    Table 75. Janssen Biotech Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022) & (US$ Million)

    Table 76. Janssen Biotech Recent Developments

    Table 77. Roche Company Details

    Table 78. Roche Business Overview

    Table 79. Roche Metastatic Malignant Melanoma Therapy Product

    Table 80. Roche Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022) & (US$ Million)

    Table 81. Roche Recent Developments

    Table 82. Navidea Company Details

    Table 83. Navidea Business Overview

    Table 84. Navidea Metastatic Malignant Melanoma Therapy Product

    Table 85. Navidea Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022) & (US$ Million)

    Table 86. Navidea Recent Developments

    Table 87. Novartis Company Details

    Table 88. Novartis Business Overview

    Table 89. Novartis Metastatic Malignant Melanoma Therapy Product

    Table 90. Novartis Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022) & (US$ Million)

    Table 91. Novartis Recent Developments

    Table 92. Bristol-Myers Squibb Company Details

    Table 93. Bristol-Myers Squibb Business Overview

    Table 94. Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Product

    Table 95. Bristol-Myers Squibb Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022) & (US$ Million)

    Table 96. Bristol-Myers Squibb Recent Developments

    Table 97. Enzon Pharmaceuticals Company Details

    Table 98. Enzon Pharmaceuticals Business Overview

    Table 99. Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Product

    Table 100. Enzon Pharmaceuticals Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022) & (US$ Million)

    Table 101. Enzon Pharmaceuticals Recent Developments

    Table 102. Exelixis Company Details

    Table 103. Exelixis Business Overview

    Table 104. Exelixis Metastatic Malignant Melanoma Therapy Product

    Table 105. Exelixis Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022) & (US$ Million)

    Table 106. Exelixis Recent Developments

    Table 107. GlaxoSmithKline Company Details

    Table 108. GlaxoSmithKline Business Overview

    Table 109. GlaxoSmithKline Metastatic Malignant Melanoma Therapy Product

    Table 110. GlaxoSmithKline Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022) & (US$ Million)

    Table 111. GlaxoSmithKline Recent Developments

    Table 112. Ono Pharmaceutical Company Details

    Table 113. Ono Pharmaceutical Business Overview

    Table 114. Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Product

    Table 115. Ono Pharmaceutical Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022) & (US$ Million)

    Table 116. Ono Pharmaceutical Recent Developments

    Table 117. Amgen Company Details

    Table 118. Amgen Business Overview

    Table 119. Amgen Metastatic Malignant Melanoma Therapy Product

    Table 120. Amgen Revenue in Metastatic Malignant Melanoma Therapy Business (2017-2022) & (US$ Million)

    Table 121. Amgen Recent Developments

    Table 122. Research Programs/Design for This Report

    Table 123. Key Data Information from Secondary Sources

    Table 124. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Metastatic Malignant Melanoma Therapy Market Share by Type: 2021 VS 2028

    Figure 2. Immunotherapy Features

    Figure 3. Targeted Therapy Features

    Figure 4. Other Features

    Figure 5. Global Metastatic Malignant Melanoma Therapy Market Share by Application: 2021 VS 2028

    Figure 6. Hospital Case Studies

    Figure 7. Medical Research Organization Case Studies

    Figure 8. Other Case Studies

    Figure 9. Metastatic Malignant Melanoma Therapy Report Years Considered

    Figure 10. Global Metastatic Malignant Melanoma Therapy Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 11. Global Metastatic Malignant Melanoma Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 12. Global Metastatic Malignant Melanoma Therapy Market Share by Region: 2021 VS 2028

    Figure 13. Global Metastatic Malignant Melanoma Therapy Market Share by Players in 2021

    Figure 14. Global Top Metastatic Malignant Melanoma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Malignant Melanoma Therapy as of 2021)

    Figure 15. The Top 10 and 5 Players Market Share by Metastatic Malignant Melanoma Therapy Revenue in 2021

    Figure 16. North America Metastatic Malignant Melanoma Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 17. North America Metastatic Malignant Melanoma Therapy Market Size Market Share by Type (2017-2028)

    Figure 18. North America Metastatic Malignant Melanoma Therapy Market Size Market Share by Application (2017-2028)

    Figure 19. North America Metastatic Malignant Melanoma Therapy Market Size Share by Country (2017-2028)

    Figure 20. United States Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 21. Canada Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 22. Europe Metastatic Malignant Melanoma Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 23. Europe Metastatic Malignant Melanoma Therapy Market Size Market Share by Type (2017-2028)

    Figure 24. Europe Metastatic Malignant Melanoma Therapy Market Size Market Share by Application (2017-2028)

    Figure 25. Europe Metastatic Malignant Melanoma Therapy Market Size Share by Country (2017-2028)

    Figure 26. Germany Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 27. France Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 28. U.K. Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 29. Italy Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 30. Russia Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 31. Nordic Countries Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 32. Asia-Pacific Metastatic Malignant Melanoma Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 33. Asia Pacific Metastatic Malignant Melanoma Therapy Market Size Market Share by Type (2017-2028)

    Figure 34. Asia Pacific Metastatic Malignant Melanoma Therapy Market Size Market Share by Application (2017-2028)

    Figure 35. Asia Pacific Metastatic Malignant Melanoma Therapy Market Size Share by Region (2017-2028)

    Figure 36. China Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 37. Japan Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 38. South Korea Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 39. Southeast Asia Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. India Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 41. Australia Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

    Figure 42. Latin America Metastatic Malignant Melanoma Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 43. Latin America Metastatic Malignant Melanoma Therapy Market Size Market Share by Type (2017-2028)

    Figure 44. Latin America Metastatic Malignant Melanoma Therapy Market Size Market Share by Application (2017-2028)

    Figure 45. Latin America Metastatic Malignant Melanoma Therapy Market Size Share by Country (2017-2028)

    Figure 46. Mexico Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 47. Brazil Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 48. Middle East & Africa Metastatic Malignant Melanoma Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 49. Middle East and Africa Metastatic Malignant Melanoma Therapy Market Size Market Share by Type (2017-2028)

    Figure 50. Middle East and Africa Metastatic Malignant Melanoma Therapy Market Size Market Share by Application (2017-2028)

    Figure 51. Middle East and Africa Metastatic Malignant Melanoma Therapy Market Size Share by Country (2017-2028)

    Figure 52. Turkey Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 53. Saudi Arabia Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 54. UAE Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 55. Merck Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2017-2022)

    Figure 56. Pfizer Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2017-2022)

    Figure 57. Janssen Biotech Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2017-2022)

    Figure 58. Roche Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2017-2022)

    Figure 59. Navidea Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2017-2022)

    Figure 60. Novartis Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2017-2022)

    Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2017-2022)

    Figure 62. Enzon Pharmaceuticals Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2017-2022)

    Figure 63. Exelixis Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2017-2022)

    Figure 64. GlaxoSmithKline Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2017-2022)

    Figure 65. Ono Pharmaceutical Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2017-2022)

    Figure 66. Amgen Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2017-2022)

    Figure 67. Bottom-up and Top-down Approaches for This Report

    Figure 68. Data Triangulation

    Figure 69. Key Executives Interviewed